Skip to main content
. 2011 Jan 14;3(1):298–318. doi: 10.3390/cancers3010298

Figure 4.

Figure 4

The CD133+ glioma stem cells in the pediatric GBM xenograft D456MG were significantly more sensitive to killing than several adult GBM xenografts tested after 72 hours of low dose infection (1 plaque-forming unit (PFU) per cell) with G207, an engineered herpes simplex virus used in adult GBM trials at the University of Alabama at Birmingham.